Skip to content

Clinical trials

Phase 2 Hepatitis C trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Country / region: Puerto Rico Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20072
20083
20094
201012
20119
20123
20133
20142
20153

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences17
AbbVie (prior sponsor, Abbott)4
Bristol-Myers Squibb3
National Institute of Allergy and Infectious Diseases (NIAID)3
Vertex Pharmaceuticals Incorporated3
Conatus Pharmaceuticals Inc.2
Debiopharm International SA2
GlaxoSmithKline2
Pfizer2
Santaris Pharma A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C45
Hepatitis C, Chronic12
Hepatitis5
HIV Infections3
Infections3
Liver Diseases2
Bronchiolitis Obliterans Syndrome1
Chronic Pain1
Thrombocytopenia1
Virus Diseases1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.